Benefits of combination therapy of insulin and oral hypoglycemic agents.
Garber
Alan J
AJ
Baylor College of Medicine, Houston, Tex 77030, USA. agarber@bcm.tmc.edu
D000284:Administration, Oral; D003920:Diabetes Mellitus / Q000097:blood / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D006442:Glycated Hemoglobin / Q000378:metabolism; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage*; D007279:Injections, Subcutaneous; D007328:Insulin / Q000008:administration & dosage*; D008687:Metformin / Q000008:administration & dosage; D011446:Prospective Studies; D016032:Randomized Controlled Trials as Topic; D013453:Sulfonylurea Compounds / Q000008:administration & dosage; D013844:Thiazoles / Q000008:administration & dosage; D045162:Thiazolidinediones; D016896:Treatment Outcome; D006113:United Kingdom; D014481:United States
D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; D007328:Insulin; D008687:Metformin; D013453:Sulfonylurea Compounds; D013844:Thiazoles; D045162:Thiazolidinediones; C089946:2,4-thiazolidinedione